Philip D Emond Net Worth

The estimated Net Worth of Philip D Emond is at least $10.7 million dollars as of 19 May 2011. Philip Emond owns over 16,066 units of Cigna stock worth over $10,717,658 and over the last 13 years Philip sold CI stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Philip Emond CI stock SEC Form 4 insiders trading

Philip has made over 1 trades of the Cigna stock since 2011, according to the Form 4 filled with the SEC. Most recently Philip exercised 16,066 units of CI stock worth $615,488 on 19 May 2011.

The largest trade Philip's ever made was exercising 16,066 units of Cigna stock on 19 May 2011 worth over $615,488. On average, Philip trades about 8,033 units every 0 days since 2011. As of 19 May 2011 Philip still owns at least 29,956 units of Cigna stock.

You can see the complete history of Philip Emond stock trades at the bottom of the page.

What's Philip Emond's mailing address?

Philip's mailing address filed with the SEC is 1601 CHESTNUT STREET, TWO LIBERTY PLACE, PHILADELPHIA, PA, 19192.

Insiders trading at Cigna

Over the last 21 years, insiders at Cigna have traded over $319,958,441 worth of Cigna stock and bought 28,308 units worth $3,902,366 . The most active insiders traders include James E Rogers, William J Iii De Laney et Eric C Wiseman. On average, Cigna executives and independent directors trade stock every 14 days with the average trade being worth of $5,384,589. The most recent stock trade was executed by William J Iii De Laney on 19 August 2024, trading 2,691 units of CI stock currently worth $471,167.

What does Cigna do?

The Cigna Group is a global health services company. The Companys portfolio of offerings solves diverse challenges across the healthcare system. The Company offers a differentiated set of pharmacy, medical, behavioral, dental and supplemental products, and services, primarily through two platforms: Evernorth Health Services and Cigna Healthcare.

Complete history of Philip Emond stock trades at Cigna

Cigna executives and stock owners

Cigna executives and other stock owners filed with the SEC include:

• Timothy Wentworth,
  President - Health Services
• David Cordani,
  President, Chief Executive Officer, Director
• Matthew Manders,
  President - Strategy and Solutions
• Eric Palmer,
  Chief Financial Officer, Executive Vice President
• David Michael Cordani,
  Chair of the Board, Pres & CEO
• Nicole Jones,
  Executive Vice President, General Counsel
• Jason Sadler,
  President - International Markets
• Eric Paul Palmer,
  Pres, COO of Evernorth & CEO of Evernorth
• Nicole Susan Jones,
  Exec. VP & Gen. Counsel
• Isaiah Harris,
  Independent Chairman of the Board
• Donna Zarcone,
  Independent Director
• Roman Martinez,
  Independent Director
• William Roper,
  Independent Director
• John Partridge,
  Independent Director
• Eric Wiseman,
  Independent Director
• Mark McClellan,
  Independent Director
• Kathleen Mazzarella,
  Independent Director
• Elder Granger,
  Independent Director
• Eric Foss,
  Independent Director
• William DeLaney,
  Independent Director
• Noelle Eder,
  Global Chief Information Officer
• John Webb,
  President - Health Care
• Kimberly Ross,
  Director
• Kristen Lauria,
  Chief Marketing Officer
• William McDowell,
  Vice President, Investor Relations
• Steven Miller,
  Executive Vice President, Chief Clinical Officer
• John Murabito,
  Executive Vice President - Human Resources and Services
• Mark Boxer,
  Executive Vice President
• Michael Triplett,
  President - U.S. Markets
• Brian Evanko,
  President - Government Business
• Cynthia Ryan,
  Exec. VP & Chief HR Officer
• Ralph Giacobbe,
  Sr. VP & Head of Investor Relations
• Everett Neville,
  Exec. VP of Strategy, Corp. Devel. & Solutions
• William McDowell III,
  VP of Investor Relations
• John M. Murabito,
  Exec. VP & Chief Admin. Officer
• Noelle K. Eder,
  Exec. VP & Global Chief Information Officer
• Mary Terese Agoglia Hoeltzel CPA,
  Sr. VP of Tax & Chief Accounting Officer
• Paul Sanford,
  Exec. VP of Operations
• Philip Ozuah,
  Director
• William D Zollars,
  Director
• Jane E Md Henney,
  Director
• James E Rogers,
  Director
• Lisa R Bacus,
  EVP, Chief Marketing Officer
• Thomas A Mc Carthy,
  Acting Chief Financial Officer
• Christopher J Hocevar,
  Pres. Strat Segmts & Solutions
• Alan Muney,
  EVP Total Hlth & Network & CMO
• Charles Berg,
  Pres, Govt Programs & Sr Advsr
• Cynthia Ryan,
  EVP, CHRO
• David J Brailer,
  EVP & Chief Health Officer
• George Kurian,
  Director
• Hoeltzel Mary T Agoglia,
  SVP Tax & Chief Acct. Officer
• Joseph P Sullivan,
  Director
• Peter N Larson,
  Director
• Michael D Woeller,
  EVP, Chief Information Officer
• Carol Cox Wait,
  Director
• William L Atwell,
  President International
• Annmarie T Hagan,
  Chief Accounting Officer
• H Edward Hanway,
  Chairman and CEO
• Robert H Campbell,
  Director
• Philip D Emond,
  EVP, Chief Information Officer
• Carol Ann Petren,
  EVP, General Counsel
• David D Guilmette,
  Pres. Nat'l, Pharm. & Product
• Bertram L Scott,
  President US Commercial
• Ralph J Nicoletti,
  EVP, Chief Financial Officer
• Neesha Hathi,
  Director
• Karen S Lynch,
  President, Group Ins.
• Michael W Bell,
  EVP, CFO
• Paul Hartley,
  President, CIGNA International
• Scott Storrer,
  Chief Information Officer
• Harold A Wagner,
  Director
• Louis W Sullivan,
  Director
• Marilyn Ware,
  Director
• Joseph Neubauer,
  Director
• Judith E Soltz,
  EVP, General Counsel
• Gregory H Wolf,
  President, Group Insurance
• Charles R Shoemate,
  Director
• Andrea Anania,
  EVP, CIO
• Terry L Kendall,
  President, International
• Herbert A Fritch,
  President, HealthSpring
• Michelle Gass,
  Director
• Paul A Sanford,
  EVP Operations
• Everett Neville,
  EVP, Solutions & Corp Devt.